Healthy postmenopausal women ( n = 119 ; age 50-70 yr ) underwent a 6-month weight-loss ( primarily exercise ) intervention with randomization to raloxifene ( 60 mg/d ) , HT ( conjugated estrogens , 0.625 mg/d ) , or placebo .